​

Addus HomeCare (ADUS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ADUS Stock Forecast

Addus HomeCare (ADUS) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $147.50, with a high of $150.00 and a low of $145.00. This represents a 45.68% increase from the last price of $101.25.

$90 $102 $114 $126 $138 $150 High: $150 Avg: $147.5 Low: $145 Last Closed Price: $101.25

ADUS Stock Rating

Addus HomeCare stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (92.86%), 0 Hold (0.00%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 1 0 13 Strong Sell Sell Hold Buy Strong Buy

ADUS Price Target Upside V Benchmarks

TypeNameUpside
StockAddus HomeCare45.68%
SectorHealthcare Stocks 35.94%
IndustryMedical Care Facilities Stocks24.63%

Price Target Trends

1M3M12M
# Anlaysts--10
Avg Price Target--$134.10
Last Closing Price$101.25$101.25$101.25
Upside/Downside--32.44%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2538--112
Mar, 2538--112
Feb, 2538--112
Jan, 2538--112
Dec, 2438--112
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 16, 2024Constantine DavidesJMP Securities$150.00$122.9621.99%48.15%
Nov 06, 2024Scott FidelStephens$145.00$124.6816.30%43.21%
Oct 10, 2024Matthew GillmorKeyBanc$150.00$127.4417.70%48.15%
Sep 23, 2024Michael WiederhornOppenheimer$145.00$131.3510.39%43.21%
Aug 08, 2024Frank MorganRBC Capital$141.00$122.2215.37%39.26%
Aug 07, 2024Michael WiederhornOppenheimer$140.00$122.2214.55%38.27%
Jun 07, 2024Michael WiederhornOppenheimer$130.00$116.0712.00%28.40%
May 31, 2024Scott FidelStephens$128.00$111.7314.56%26.42%
May 28, 2024Frank MorganRBC Capital$129.00$111.6115.58%27.41%
Apr 23, 2024Andrew MokBarclays$83.00$93.15-10.90%-18.02%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 16, 2024JMP SecuritiesOutperforminitialise
Oct 11, 2024StephensBuyBuyhold
Oct 10, 2024KeyBancOverweightinitialise
Sep 23, 2024OppenheimerOutperformOutperformhold
Sep 03, 2024StephensBuyBuyhold
Aug 08, 2024Cowen & Co.BuyBuyhold
Aug 08, 2024RBC CapitalOutperformOutperformhold
Aug 07, 2024OppenheimerOutperformOutperformhold
Aug 07, 2024StephensOverweightOverweighthold
Aug 06, 2024OppenheimerUnderperformUnderperformhold

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$2.12$2.87$2.90$3.85$4.23---
Avg Forecast$2.98$3.42$3.53$4.36$5.23$6.06$6.74$7.46
High Forecast$3.25$3.72$3.59$4.40$5.31$6.25$7.39$7.88
Low Forecast$2.81$3.23$3.47$4.31$5.12$5.85$6.05$7.04
Surprise %-28.86%-16.08%-17.85%-11.70%-19.12%---

Revenue Forecast

$500M $800M $1B $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$764.77M$864.50M$951.12M$1.06B$1.15B---
Avg Forecast$766.33M$865.59M$950.22M$1.06B$1.15B$1.43B$1.52B$1.68B
High Forecast$818.89M$924.95M$962.51M$1.10B$1.20B$1.50B$1.52B$1.76B
Low Forecast$733.16M$828.12M$937.59M$1.05B$1.12B$1.40B$1.52B$1.64B
Surprise %-0.20%-0.13%0.10%0.18%0.49%---

Net Income Forecast

$0 $30M $60M $90M $120M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$33.13M$45.13M$46.02M$62.52M$73.60M---
Avg Forecast$25.85M$44.99M$46.36M$62.52M$85.03M$101.08M$112.15M$125.38M
High Forecast$31.02M$53.99M$55.63M$75.02M$86.58M$101.98M$120.47M$128.49M
Low Forecast$20.68M$35.99M$37.09M$50.01M$83.48M$95.38M$98.71M$114.87M
Surprise %28.19%0.31%-0.72%--13.45%---

ADUS Forecast FAQ

Is Addus HomeCare stock a buy?

Addus HomeCare stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 0 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Addus HomeCare is a favorable investment for most analysts.

What is Addus HomeCare's price target?

Addus HomeCare's price target, set by 14 Wall Street analysts, averages $147.5 over the next 12 months. The price target range spans from $145 at the low end to $150 at the high end, suggesting a potential 45.68% change from the previous closing price of $101.25.

How does Addus HomeCare stock forecast compare to its benchmarks?

Addus HomeCare's stock forecast shows a 45.68% upside, outperforming the average forecast for the healthcare stocks sector (35.94%) and outperforming the medical care facilities stocks industry (24.63%).

What is the breakdown of analyst ratings for Addus HomeCare over the past three months?

  • April 2025: 25.00% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 8.33% Strong Sell.
  • March 2025: 25.00% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 8.33% Strong Sell.
  • February 2025: 25.00% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 8.33% Strong Sell.

What is Addus HomeCare’s EPS forecast?

Addus HomeCare's average annual EPS forecast for its fiscal year ending in December 2025 is $6.06, marking a 43.26% increase from the reported $4.23 in 2024. Estimates for the following years are $6.74 in 2026, and $7.46 in 2027.

What is Addus HomeCare’s revenue forecast?

Addus HomeCare's average annual revenue forecast for its fiscal year ending in December 2025 is $1.43B, reflecting a 23.97% increase from the reported $1.15B in 2024. The forecast for 2026 is $1.52B, and $1.68B for 2027.

What is Addus HomeCare’s net income forecast?

Addus HomeCare's net income forecast for the fiscal year ending in December 2025 stands at $101.08M, representing an 37.34% increase from the reported $73.6M in 2024. Projections indicate $112.15M in 2026, and $125.38M in 2027.